Viela Bio's journey to market with its first drug hasn't been without its bumps. But it's forging on.

The Gaithersburg biotech's drug is aimed at treating a life-threatening autoimmune disease called neuromyelitis optica spectrum disorder.

Source: bizjournals.com Health Care:Biotechnology headlines - July 23, 2020 Category: Biotechnology Authors: Sara Gilgore Source Type: news